Elicio Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $-18.6M | $5.6M |
| FY2020 | $635.0K | $-90.4M | $34.6M |
| FY2021 | $0 | $-74.5M | $88.8M |
| FY2022 | — | $-102.1M | $6.2M |
| FY2023 | — | $11.4M | $12.9M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $-18.6M | $5.6M |
| FY2020 | $635.0K | $-90.4M | $34.6M |
| FY2021 | $0 | $-74.5M | $88.8M |
| FY2022 | — | $-102.1M | $6.2M |
| FY2023 | — | $11.4M | $12.9M |